Search
for
Sort by
Research 391–420 of 1000+
- Treatment of hyperandrogenic alopecia in women
- Congenital Adrenal Hyperplasia
- Androgen excess is the key element in polycystic ovary syndrome
- Defining hirsutism in Chinese women: a cross-sectional study
- Polycystic Ovary Syndrome
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Diagnosis of hyperandrogenism: Biochemical criteria
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Dermatology of androgen-related disorders
- Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling.
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Nonclassic Congenital Adrenal Hyperplasia
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women
- Mood disorders and quality of life in polycystic ovary syndrome
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess